<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00304031</url>
  </required_header>
  <id_info>
    <org_study_id>RTOG-0525</org_study_id>
    <secondary_id>CDR0000465183</secondary_id>
    <secondary_id>EORTC-26052</secondary_id>
    <secondary_id>EORTC-22053</secondary_id>
    <secondary_id>NCI-2009-00731</secondary_id>
    <nct_id>NCT00304031</nct_id>
  </id_info>
  <brief_title>Radiation Therapy (RT) and Temozolomide (TMZ) in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma</brief_title>
  <official_title>Phase III Trial Comparing Conventional Adjuvant Temozolomide With Dose-Intensive Temozolomide in Patients With Newly Diagnosed Glioblastoma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Radiation Therapy Oncology Group</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>European Organisation for Research and Treatment of Cancer - EORTC</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>NRG Oncology</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Radiation Therapy Oncology Group</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      RATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells. Drugs used in
      chemotherapy, such as temozolomide, work in different ways to stop the growth of tumor cells,
      either by killing the cells or by stopping them from dividing. Giving radiation therapy
      together with temozolomide may kill more tumor cells. It is not yet known which schedule of
      temozolomide when given together with radiation therapy is more effective in treating
      glioblastoma or gliosarcoma.

      PURPOSE: This randomized phase III trial is studying two different schedules of temozolomide
      to compare how well they work when given together with radiation therapy in treating patients
      with newly diagnosed glioblastoma or gliosarcoma.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      OBJECTIVES:

      Primary

        -  Determine if dose-intensifying (increasing the &quot;dose-density&quot;) the adjuvant temozolomide
           component of the chemoradiation treatment enhances treatment efficacy as measured by
           overall survival of patients with newly diagnosed glioblastoma or gliosarcoma.

      Secondary

        -  Determine if dose-intensifying the adjuvant temozolomide component of the chemoradiation
           treatment enhances treatment efficacy as measured by progression-free survival.

        -  Determine in patients with unmethylated MGMT (O6-methylguanine-DNA methyltransferase) if
           dose-intensifying the adjuvant temozolomide component of the chemoradiation treatment
           enhances treatment efficacy (overall and progression-free survival) compared with
           patients receiving conventional temozolomide dosing.

        -  Determine in patients with methylated MGMT if dose-intensifying the adjuvant
           temozolomide component of the chemoradiation treatment enhances treatment efficacy
           (overall and progression-free survival) compared with patients receiving conventional
           temozolomide dosing.

        -  Determine if there is an association between tumor MGMT gene methylation status and
           treatment response.

        -  Compare and record the toxicities of the conventional and dose-intense chemotherapy
           regimens.

        -  Evaluate whether 6-month progression-free survival is associated with overall survival.

      OUTLINE: This is a randomized, multicenter study. Patients are stratified according to
      recursive partitioning analysis class (III vs IV vs V), MGMT gene methylation status
      (methylated vs nonmethylated vs indeterminate), and radiotherapy criteria used (standard vs
      revised European).

      Patients undergo radiotherapy daily, 5 days per week for 6 weeks. Patients also receive oral
      temozolomide daily during radiotherapy. Patients are then randomized to 1 of 2 treatment
      arms. Randomized treatment begins approximately 4 weeks after completion of radiotherapy.

        -  Arm I: Patients receive oral temozolomide on days 1-5.

        -  Arm II: Patients receive oral temozolomide on days 1-21. In both arms, treatment repeats
           every 28 days for up to 6 courses in the absence of disease progression or unacceptable
           toxicity. Patients with responding disease may receive up to 6 more courses of
           temozolomide.

      After completion of study treatment, patients are followed every 3 months for 1 year, every 4
      months for 2 years, and then every 6 months thereafter.

      Peer Reviewed and Funded or Endorsed by Cancer Research UK

      PROJECTED ACCRUAL: This study requires 750 patients randomized to the two treatment arms.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2006</start_date>
  <completion_date type="Actual">December 2016</completion_date>
  <primary_completion_date type="Actual">February 2011</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Overall Survival (OS)</measure>
    <time_frame>From randomization to date of death or last follow-up. Analysis occurs after 647 deaths have been reported.</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Progression-free Survival (PFS)</measure>
    <time_frame>From randomization to date of progression, death or last follow-up. Analysis occurs after 647 deaths have been reported.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison of OS and PFS in Patients With Unmethylated MGMT</measure>
    <time_frame>From randomization to date of progression, death or last follow-up. Analysis occurs after 647 deaths have been reported.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison of OS and PFS in Patients With Methylated MGMT</measure>
    <time_frame>From randomization to date of progression, death or last follow-up. Analysis occurs after 647 deaths have been reported.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation of Tumor MGMT Gene Methylation Status With Treatment Response</measure>
    <time_frame>From randomization to date of progression, death or last follow-up. Analysis occurs after 647 deaths have been reported.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Toxicity</measure>
    <time_frame>From start of treatment to end of follow-up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation of PFS With OS at 6 Months</measure>
    <time_frame>From randomization to date of progression, death or last follow-up. Analysis occurs after 647 deaths have been reported.</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">1173</enrollment>
  <condition>Brain and Central Nervous System Tumors</condition>
  <arm_group>
    <arm_group_label>Conventional adjuvant TMZ</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Concurrent radiation therapy with concurrent temozolomide (75 mg/m2) up to 49 doses. Starting four weeks after completion of RT, 100mg/m2 adjuvant temozolomide days 1 to 5 of 28 day cycle.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dose-dense adjuvant TMZ</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Concurrent radiation therapy (RT) with concurrent temozolomide (75 mg/m2) up to 49 doses. Starting four weeks after completion of RT, 75mg/m2 adjuvant temozolomide days 1-21 of 28 day cycle.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No adjuvant TMZ (not randomized )</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Concurrent radiation therapy (RT) with concurrent temozolomide (75 mg/m2) up to 49 doses. Not randomized to either adjuvant TMZ arm.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Concurrent temozolomide</intervention_name>
    <description>Daily oral temozolomide (75 mg/m2) up to 49 doses.</description>
    <arm_group_label>Conventional adjuvant TMZ</arm_group_label>
    <arm_group_label>Dose-dense adjuvant TMZ</arm_group_label>
    <arm_group_label>No adjuvant TMZ (not randomized )</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Concurrent radiation therapy</intervention_name>
    <description>60 Gy in 2 Gy fractions</description>
    <arm_group_label>Conventional adjuvant TMZ</arm_group_label>
    <arm_group_label>Dose-dense adjuvant TMZ</arm_group_label>
    <arm_group_label>No adjuvant TMZ (not randomized )</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>100mg/m2 adjuvant temozolomide days 1 to 5 of 28 day cycle</intervention_name>
    <description>Oral temozolomide on days 1-5 of a 28-day cycle. Dose starts at 150mg/m2 for first cycle, increases to 200mg/m2 for subsequent cycles if no unacceptable toxicity. Treatment repeats every 28 days for up to 6 courses in the absence of disease progression or unacceptable toxicity. Patients with responding disease may receive up to 6 more courses of temozolomide.</description>
    <arm_group_label>Conventional adjuvant TMZ</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>75mg/m2 adjuvant temozolomide days 1-21 of 28 day cycle</intervention_name>
    <description>Oral temozolomide on days 1-21 of a 28-day cycle. Dose starts at 75mg/m2 for first cycle, increases to 100mg/m2 for subsequent cycles if no unacceptable toxicity. Treatment repeats every 28 days for up to 6 courses in the absence of disease progression or unacceptable toxicity. Patients with responding disease may receive up to 6 more courses of temozolomide.</description>
    <arm_group_label>Dose-dense adjuvant TMZ</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        DISEASE CHARACTERISTICS:

          -  Histologically proven glioblastoma or gliosarcoma

               -  Diagnosis must be made by open biopsy or tumor resection

                    -  Diagnosis by stereotactic biopsy not allowed

               -  Tumor must have supratentorial component

               -  Contrast-enhanced MRI or CT scan (if MRI is not available) of the brain must be
                  performed preoperatively and postoperatively prior to initiation of radiotherapy,
                  within 28 days prior to study entry

                    -  If pre- and postoperative contrast-enhanced CT scans are obtained, must be
                       of sufficient quality

          -  Meets 1 of the following recursive positioning analysis classifications:

               -  Class III

                    -  Age &lt; 50 years and Karnofsky performance status (KPS) 90-100%

               -  Class IV, meeting 1 of the following criteria:

                    -  Age &lt; 50 years and KPS &lt; 90%

                    -  Age ≥ 50 years and KPS 70-100% and underwent prior partial or total tumor
                       resection with no worse than minor neurofunction impairment

               -  Class V, meeting 1 of the following criteria:

                    -  Age ≥ 50 years and KPS 70-100% and underwent prior partial or total tumor
                       resection with worse than minor neurofunction impairment

                    -  Age ≥ 50 years and KPS 70-100% and underwent prior tumor biopsy only

                    -  Age ≥ 50 years and KPS &lt; 70%

          -  Underwent most recent brain tumor surgery within the past 5 weeks

          -  No recurrent or multifocal malignant gliomas

          -  At least 1 block of tissue available for analysis of MGMT gene methylation status

          -  No metastases detected below the tentorium or beyond the cranial vault

        PATIENT CHARACTERISTICS:

          -  KPS 60-100%

          -  Absolute neutrophil count ≥ 1,500 cells/mm^3

          -  Platelet count ≥ 100,000 cells/mm^3

          -  Hemoglobin ≥ 10 g/dL (transfusion or other intervention allowed)

          -  BUN (blood urea nitrogen) ≤ 25 mg/dL

          -  Creatinine ≤ 1.7 mg/dL

          -  Bilirubin ≤ 2.0 mg/dL

          -  AST (aspartate aminotransferase ) and ALT (alanine amino transferase) ≤ 3 times normal

          -  Negative pregnancy test

          -  Not pregnant or nursing

          -  Fertile patients must use effective contraception

          -  No prior invasive malignancy (except for nonmelanomatous skin cancer) unless patient
             is disease free for ≥ 3 years (e.g., carcinoma in situ of the breast, oral cavity, or
             cervix allowed)

          -  No severe, active comorbidity, including any of the following:

               -  Unstable angina and/or congestive heart failure requiring hospitalization

               -  Transmural myocardial infarction within the last 6 months

               -  Acute bacterial or fungal infection requiring intravenous antibiotics at the time
                  of registration

               -  Chronic obstructive pulmonary disease exacerbation or other respiratory illness
                  requiring hospitalization or precluding study therapy at the time of registration

               -  Known hepatic insufficiency resulting in clinical jaundice and/or coagulation
                  defects

               -  Known AIDS based upon current CDC (Center for Disease Control) definition

               -  Major medical illnesses or psychiatric impairments that, in the investigator's
                  opinion, will prevent administration or completion of protocol therapy

               -  Active connective tissue disorders, such as lupus or scleredema that, in the
                  opinion of the treating physician, may put the patient at high risk for radiation
                  toxicity

          -  No prior allergic reaction to temozolomide

        PRIOR CONCURRENT THERAPY:

          -  See Disease Characteristics

          -  Recovered from the effects of surgery, postoperative infection, and other
             complications prior to study entry

          -  No prior chemotherapy or radiosensitizers (including polifeprosan 20 with carmustine
             implant [Gliadel wafers] or any other intratumoral or intracavitary treatment) for
             cancers of the head and neck region

               -  Prior chemotherapy for a different cancer is allowed

          -  No prior radiotherapy to the head or neck (except for T1 glottic cancer) that would
             result in an overlap of radiation fields

          -  No treatment on other therapeutic clinical protocols within 30 days prior to study
             entry or during participation in the study

          -  No concurrent prophylactic growth factors

          -  No other concurrent investigational drugs

          -  No concurrent surgical procedures for tumor debulking

          -  No other concurrent chemotherapy, immunotherapy, or biologic therapy

          -  No additional concurrent stereotactic boost radiotherapy

          -  No concurrent intensity-modulated radiotherapy

          -  Concurrent steroids allowed provided dose is stable or decreasing in the past 5 days
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>120 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mark R. Gilbert, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>M.D. Anderson Cancer Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Minesh P. Mehta, MD</last_name>
    <role>Study Chair</role>
    <affiliation>University of Wisconsin, Madison</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Roger Stupp, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Centre Hospitalier Universitaire Vaudois</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Fairbanks Cancer Treatment Center at Fairbanks Memorial Hospital</name>
      <address>
        <city>Fairbanks</city>
        <state>Alaska</state>
        <zip>99701</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Arizona Oncology Services Foundation</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85013</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic Scottsdale</name>
      <address>
        <city>Scottsdale</city>
        <state>Arizona</state>
        <zip>85259-5499</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Arizona Oncology - Tucson</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85704</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Auburn Radiation Oncology</name>
      <address>
        <city>Auburn</city>
        <state>California</state>
        <zip>95603</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Providence Saint Joseph Medical Center - Burbank</name>
      <address>
        <city>Burbank</city>
        <state>California</state>
        <zip>91505</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Radiation Oncology Centers - Cameron Park</name>
      <address>
        <city>Cameron Park</city>
        <state>California</state>
        <zip>95682</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mercy Cancer Center at Mercy San Juan Medical Center</name>
      <address>
        <city>Carmichael</city>
        <state>California</state>
        <zip>95608</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>City of Hope Comprehensive Cancer Center</name>
      <address>
        <city>Duarte</city>
        <state>California</state>
        <zip>91010-3000</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kaiser Permanente Medical Center - Los Angeles</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90027</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Radiation Oncology Center - Roseville</name>
      <address>
        <city>Roseville</city>
        <state>California</state>
        <zip>95661</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Radiological Associates of Sacramento Medical Group, Incorporated</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95815</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mercy General Hospital</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95819</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UCSF Helen Diller Family Comprehensive Cancer Center</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94115</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Solano Radiation Oncology Center</name>
      <address>
        <city>Vacaville</city>
        <state>California</state>
        <zip>95687</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Penrose Cancer Center at Penrose Hospital</name>
      <address>
        <city>Colorado Springs</city>
        <state>Colorado</state>
        <zip>80933</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Poudre Valley Radiation Oncology</name>
      <address>
        <city>Fort Collins</city>
        <state>Colorado</state>
        <zip>80528</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Yale Cancer Center</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06520-8028</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tunnell Cancer Center at Beebe Medical Center</name>
      <address>
        <city>Lewes</city>
        <state>Delaware</state>
        <zip>19958</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CCOP - Christiana Care Health Services</name>
      <address>
        <city>Newark</city>
        <state>Delaware</state>
        <zip>19713</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eugene M. and Christine E. Lynn Cancer Institute at Boca Raton Community Hospital - Main Campus</name>
      <address>
        <city>Boca Raton</city>
        <state>Florida</state>
        <zip>33486</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Florida Shands Cancer Center</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32610-0232</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Integrated Community Oncology Network</name>
      <address>
        <city>Jacksonville Beach</city>
        <state>Florida</state>
        <zip>32250</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Baptist Cancer Institute - Jacksonville</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32207</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Integrated Community Oncology Network at Southside Cancer Center</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32207</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic - Jacksonville</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32224</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Baptist Medical Center South</name>
      <address>
        <city>Jascksonville</city>
        <state>Florida</state>
        <zip>32258</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Baptist-South Miami Regional Cancer Program</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33176</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Integrated Community Oncology Network - Orange Park</name>
      <address>
        <city>Orange Park</city>
        <state>Florida</state>
        <zip>32073</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Florida Cancer Center - Palatka</name>
      <address>
        <city>Palatka</city>
        <state>Florida</state>
        <zip>32177</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Flagler Cancer Center</name>
      <address>
        <city>Saint Augustine</city>
        <state>Florida</state>
        <zip>32086</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>H. Lee Moffitt Cancer Center and Research Institute at University of South Florida</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33612-9497</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Piedmont Hospital</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30309</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>John B. Amos Cancer Center</name>
      <address>
        <city>Columbus</city>
        <state>Georgia</state>
        <zip>31904</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center</name>
      <address>
        <city>Boise</city>
        <state>Idaho</state>
        <zip>83706</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Northwest Community Hospital</name>
      <address>
        <city>Arlington Heights</city>
        <state>Illinois</state>
        <zip>60005</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rush-Copley Cancer Care Center</name>
      <address>
        <city>Aurora</city>
        <state>Illinois</state>
        <zip>60504</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Joseph Medical Center</name>
      <address>
        <city>Bloomington</city>
        <state>Illinois</state>
        <zip>61701</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Graham Hospital</name>
      <address>
        <city>Canton</city>
        <state>Illinois</state>
        <zip>61520</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Memorial Hospital</name>
      <address>
        <city>Carthage</city>
        <state>Illinois</state>
        <zip>62321</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>John H. Stroger, Jr. Hospital of Cook County</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612-3785</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Chicago Cancer Research Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60637-1470</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eureka Community Hospital</name>
      <address>
        <city>Eureka</city>
        <state>Illinois</state>
        <zip>61530</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Galesburg Clinic, PC</name>
      <address>
        <city>Galesburg</city>
        <state>Illinois</state>
        <zip>61401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Galesburg Cottage Hospital</name>
      <address>
        <city>Galesburg</city>
        <state>Illinois</state>
        <zip>61401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>InterCommunity Cancer Center of Western Illinois</name>
      <address>
        <city>Galesburg</city>
        <state>Illinois</state>
        <zip>61401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mason District Hospital</name>
      <address>
        <city>Havana</city>
        <state>Illinois</state>
        <zip>62644</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hopedale Medical Complex</name>
      <address>
        <city>Hopedale</city>
        <state>Illinois</state>
        <zip>61747</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Joliet Oncology-Hematology Associates, Limited - West</name>
      <address>
        <city>Joliet</city>
        <state>Illinois</state>
        <zip>60435</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>McDonough District Hospital</name>
      <address>
        <city>Macomb</city>
        <state>Illinois</state>
        <zip>61455</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardinal Bernardin Cancer Center at Loyola University Medical Center</name>
      <address>
        <city>Maywood</city>
        <state>Illinois</state>
        <zip>60153</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>BroMenn Regional Medical Center</name>
      <address>
        <city>Normal</city>
        <state>Illinois</state>
        <zip>61761</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Community Cancer Center</name>
      <address>
        <city>Normal</city>
        <state>Illinois</state>
        <zip>61761</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Community Hospital of Ottawa</name>
      <address>
        <city>Ottawa</city>
        <state>Illinois</state>
        <zip>61350</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oncology Hematology Associates of Central Illinois, PC - Ottawa</name>
      <address>
        <city>Ottawa</city>
        <state>Illinois</state>
        <zip>61350</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cancer Treatment Center at Pekin Hospital</name>
      <address>
        <city>Pekin</city>
        <state>Illinois</state>
        <zip>61554</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Proctor Hospital</name>
      <address>
        <city>Peoria</city>
        <state>Illinois</state>
        <zip>61614</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>OSF St. Francis Medical Center</name>
      <address>
        <city>Peoria</city>
        <state>Illinois</state>
        <zip>61615-7827</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CCOP - Illinois Oncology Research Association</name>
      <address>
        <city>Peoria</city>
        <state>Illinois</state>
        <zip>61615</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oncology Hematology Associates of Central Illinois, PC - Peoria</name>
      <address>
        <city>Peoria</city>
        <state>Illinois</state>
        <zip>61615</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Methodist Medical Center of Illinois</name>
      <address>
        <city>Peoria</city>
        <state>Illinois</state>
        <zip>61636</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Illinois Valley Community Hospital</name>
      <address>
        <city>Peru</city>
        <state>Illinois</state>
        <zip>61354</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Perry Memorial Hospital</name>
      <address>
        <city>Princeton</city>
        <state>Illinois</state>
        <zip>61356</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Margaret's Hospital</name>
      <address>
        <city>Spring Valley</city>
        <state>Illinois</state>
        <zip>61362</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Valley Cancer Center</name>
      <address>
        <city>Spring Valley</city>
        <state>Illinois</state>
        <zip>61362</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Carle Cancer Center at Carle Foundation Hospital</name>
      <address>
        <city>Urbana</city>
        <state>Illinois</state>
        <zip>61801</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CCOP - Carle Cancer Center</name>
      <address>
        <city>Urbana</city>
        <state>Illinois</state>
        <zip>61801</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Elkhart General Hospital</name>
      <address>
        <city>Elkhart</city>
        <state>Indiana</state>
        <zip>46515</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Radiation Oncology Associates Southwest</name>
      <address>
        <city>Fort Wayne</city>
        <state>Indiana</state>
        <zip>46804</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Parkview Regional Cancer Center at Parkview Health</name>
      <address>
        <city>Fort Wayne</city>
        <state>Indiana</state>
        <zip>46805</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Central Indiana Cancer Centers - East</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46219</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Howard Community Hospital</name>
      <address>
        <city>Kokomo</city>
        <state>Indiana</state>
        <zip>46904</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Center for Cancer Therapy at LaPorte Hospital and Health Services</name>
      <address>
        <city>La Porte</city>
        <state>Indiana</state>
        <zip>46350</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Anthony Memorial Health Centers</name>
      <address>
        <city>Michigan City</city>
        <state>Indiana</state>
        <zip>46360</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CCOP - Northern Indiana CR Consortium</name>
      <address>
        <city>South Bend</city>
        <state>Indiana</state>
        <zip>46601</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Memorial Hospital of South Bend</name>
      <address>
        <city>South Bend</city>
        <state>Indiana</state>
        <zip>46601</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Joseph Regional Medical Center</name>
      <address>
        <city>South Bend</city>
        <state>Indiana</state>
        <zip>46617</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>South Bend Clinic</name>
      <address>
        <city>South Bend</city>
        <state>Indiana</state>
        <zip>46617</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>McFarland Clinic, PC</name>
      <address>
        <city>Ames</city>
        <state>Iowa</state>
        <zip>50010</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mercy Capitol Hospital</name>
      <address>
        <city>Des Moines</city>
        <state>Iowa</state>
        <zip>50307</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CCOP - Iowa Oncology Research Association</name>
      <address>
        <city>Des Moines</city>
        <state>Iowa</state>
        <zip>50309</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>John Stoddard Cancer Center at Iowa Methodist Medical Center</name>
      <address>
        <city>Des Moines</city>
        <state>Iowa</state>
        <zip>50309</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Oncology and Hematology Associates at John Stoddard Cancer Center</name>
      <address>
        <city>Des Moines</city>
        <state>Iowa</state>
        <zip>50309</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Oncology and Hematology Associates at Mercy Cancer Center</name>
      <address>
        <city>Des Moines</city>
        <state>Iowa</state>
        <zip>50314</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mercy Cancer Center at Mercy Medical Center - Des Moines</name>
      <address>
        <city>Des Moines</city>
        <state>Iowa</state>
        <zip>50314</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>John Stoddard Cancer Center at Iowa Lutheran Hospital</name>
      <address>
        <city>Des Moines</city>
        <state>Iowa</state>
        <zip>50316</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mercy Cancer Center at Mercy Medical Center - North Iowa</name>
      <address>
        <city>Mason City</city>
        <state>Iowa</state>
        <zip>50401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cancer Center of Kansas, PA - Chanute</name>
      <address>
        <city>Chanute</city>
        <state>Kansas</state>
        <zip>66720</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cancer Center of Kansas, PA - Dodge City</name>
      <address>
        <city>Dodge City</city>
        <state>Kansas</state>
        <zip>67801</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cancer Center of Kansas, PA - El Dorado</name>
      <address>
        <city>El Dorado</city>
        <state>Kansas</state>
        <zip>67042</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cancer Center of Kansas-Independence</name>
      <address>
        <city>Independence</city>
        <state>Kansas</state>
        <zip>67301</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cancer Center of Kansas, PA - Kingman</name>
      <address>
        <city>Kingman</city>
        <state>Kansas</state>
        <zip>67068</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Southwest Medical Center</name>
      <address>
        <city>Liberal</city>
        <state>Kansas</state>
        <zip>67901</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cancer Center of Kansas, PA - Newton</name>
      <address>
        <city>Newton</city>
        <state>Kansas</state>
        <zip>67114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Menorah Medical Center</name>
      <address>
        <city>Overland Park</city>
        <state>Kansas</state>
        <zip>66209</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kansas City Cancer Centers - Southwest</name>
      <address>
        <city>Overland Park</city>
        <state>Kansas</state>
        <zip>66210</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cancer Center of Kansas, PA - Parsons</name>
      <address>
        <city>Parsons</city>
        <state>Kansas</state>
        <zip>67357</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cancer Center of Kansas, PA - Pratt</name>
      <address>
        <city>Pratt</city>
        <state>Kansas</state>
        <zip>67124</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cancer Center of Kansas, PA - Salina</name>
      <address>
        <city>Salina</city>
        <state>Kansas</state>
        <zip>67042</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Shawnee Mission Medical Center</name>
      <address>
        <city>Shawnee Mission</city>
        <state>Kansas</state>
        <zip>66204</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cancer Center of Kansas, PA - Wellington</name>
      <address>
        <city>Wellington</city>
        <state>Kansas</state>
        <zip>67152</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Associates in Womens Health, PA - North Review</name>
      <address>
        <city>Wichita</city>
        <state>Kansas</state>
        <zip>67208</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cancer Center of Kansas, PA - Medical Arts Tower</name>
      <address>
        <city>Wichita</city>
        <state>Kansas</state>
        <zip>67208</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cancer Center of Kansas, PA - Wichita</name>
      <address>
        <city>Wichita</city>
        <state>Kansas</state>
        <zip>67214</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CCOP - Wichita</name>
      <address>
        <city>Wichita</city>
        <state>Kansas</state>
        <zip>67214</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Via Christi Cancer Center at Via Christi Regional Medical Center</name>
      <address>
        <city>Wichita</city>
        <state>Kansas</state>
        <zip>67214</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wesley Medical Center</name>
      <address>
        <city>Wichita</city>
        <state>Kansas</state>
        <zip>67214</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cancer Center of Kansas, PA - Winfield</name>
      <address>
        <city>Winfield</city>
        <state>Kansas</state>
        <zip>67156</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>DeCesaris Cancer Institute at Anne Arundel Medical Center</name>
      <address>
        <city>Annapolis</city>
        <state>Maryland</state>
        <zip>21401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Agnes Hospital Cancer Center</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21229</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Union Hospital Cancer Program at Union Hospital</name>
      <address>
        <city>Elkton MD</city>
        <state>Maryland</state>
        <zip>21921</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hickman Cancer Center at Bixby Medical Center</name>
      <address>
        <city>Adrian</city>
        <state>Michigan</state>
        <zip>49221</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Joseph Mercy Cancer Center</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48106-0995</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CCOP - Michigan Cancer Research Consortium</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oakwood Cancer Center at Oakwood Hospital and Medical Center</name>
      <address>
        <city>Dearborn</city>
        <state>Michigan</state>
        <zip>48123-2500</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Josephine Ford Cancer Center at Henry Ford Hospital</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Green Bay Oncology, Limited - Escanaba</name>
      <address>
        <city>Escanaba</city>
        <state>Michigan</state>
        <zip>49431</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Genesys Hurley Cancer Institute</name>
      <address>
        <city>Flint</city>
        <state>Michigan</state>
        <zip>48503</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hurley Medical Center</name>
      <address>
        <city>Flint</city>
        <state>Michigan</state>
        <zip>48503</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Van Elslander Cancer Center at St. John Hospital and Medical Center</name>
      <address>
        <city>Grosse Pointe Woods</city>
        <state>Michigan</state>
        <zip>48236</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dickinson County Healthcare System</name>
      <address>
        <city>Iron Mountain</city>
        <state>Michigan</state>
        <zip>49801</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Foote Memorial Hospital</name>
      <address>
        <city>Jackson</city>
        <state>Michigan</state>
        <zip>49201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Borgess Medical Center</name>
      <address>
        <city>Kalamazoo</city>
        <state>Michigan</state>
        <zip>49001</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>West Michigan Cancer Center</name>
      <address>
        <city>Kalamazoo</city>
        <state>Michigan</state>
        <zip>49007-3731</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bronson Methodist Hospital</name>
      <address>
        <city>Kalamazoo</city>
        <state>Michigan</state>
        <zip>49007</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Haematology-Oncology Associates of Ohio and Michigan, PC</name>
      <address>
        <city>Lambertville</city>
        <state>Michigan</state>
        <zip>48144</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sparrow Regional Cancer Center</name>
      <address>
        <city>Lansing</city>
        <state>Michigan</state>
        <zip>48912-1811</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Mary Mercy Hospital</name>
      <address>
        <city>Livonia</city>
        <state>Michigan</state>
        <zip>48154</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Community Cancer Center of Monroe</name>
      <address>
        <city>Monroe</city>
        <state>Michigan</state>
        <zip>48162</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mercy Memorial Hospital - Monroe</name>
      <address>
        <city>Monroe</city>
        <state>Michigan</state>
        <zip>48162</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Joseph Mercy Oakland</name>
      <address>
        <city>Pontiac</city>
        <state>Michigan</state>
        <zip>48341-2985</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mercy Regional Cancer Center at Mercy Hospital</name>
      <address>
        <city>Port Huron</city>
        <state>Michigan</state>
        <zip>48060</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>William Beaumont Hospital - Royal Oak Campus</name>
      <address>
        <city>Royal Oak</city>
        <state>Michigan</state>
        <zip>48073</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Seton Cancer Institute at Saint Mary's - Saginaw</name>
      <address>
        <city>Saginaw</city>
        <state>Michigan</state>
        <zip>48601</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Providence Cancer Institute at Providence Hospital - Southfield Campus</name>
      <address>
        <city>Southfield</city>
        <state>Michigan</state>
        <zip>48075</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lakeland Regional Cancer Care Center - St. Joseph</name>
      <address>
        <city>St. Joseph</city>
        <state>Michigan</state>
        <zip>49085</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. John Macomb Hospital</name>
      <address>
        <city>Warren</city>
        <state>Michigan</state>
        <zip>48093</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Alexandria</city>
        <state>Minnesota</state>
        <zip>56308</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MeritCare Bemidji</name>
      <address>
        <city>Bemidji</city>
        <state>Minnesota</state>
        <zip>56601</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fairview Ridges Hospital</name>
      <address>
        <city>Burnsville</city>
        <state>Minnesota</state>
        <zip>55337</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mercy and Unity Cancer Center at Mercy Hospital</name>
      <address>
        <city>Coon Rapids</city>
        <state>Minnesota</state>
        <zip>55433</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fairview Southdale Hospital</name>
      <address>
        <city>Edina</city>
        <state>Minnesota</state>
        <zip>55435</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Fergus Falls</city>
        <state>Minnesota</state>
        <zip>56537</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mercy and Unity Cancer Center at Unity Hospital</name>
      <address>
        <city>Fridley</city>
        <state>Minnesota</state>
        <zip>55432</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Minnesota Oncology Hematology, PA - Maplewood</name>
      <address>
        <city>Maplewood</city>
        <state>Minnesota</state>
        <zip>55109</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Virginia Piper Cancer Institute at Abbott - Northwestern Hospital</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55407</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hubert H. Humphrey Cancer Center at North Memorial Outpatient Center</name>
      <address>
        <city>Robbinsdale</city>
        <state>Minnesota</state>
        <zip>55422-2900</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic Cancer Center</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CentraCare Clinic - River Campus</name>
      <address>
        <city>Saint Cloud</city>
        <state>Minnesota</state>
        <zip>56303</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Coborn Cancer Center</name>
      <address>
        <city>Saint Cloud</city>
        <state>Minnesota</state>
        <zip>56303</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CCOP - Metro-Minnesota</name>
      <address>
        <city>Saint Louis Park</city>
        <state>Minnesota</state>
        <zip>55416</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Park Nicollet Cancer Center</name>
      <address>
        <city>Saint Louis Park</city>
        <state>Minnesota</state>
        <zip>55416</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>United Hospital</name>
      <address>
        <city>Saint Paul</city>
        <state>Minnesota</state>
        <zip>55102</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ridgeview Medical Center</name>
      <address>
        <city>Waconia</city>
        <state>Minnesota</state>
        <zip>55387</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Minnesota Oncology Hematology, PA - Woodbury</name>
      <address>
        <city>Woodbury</city>
        <state>Minnesota</state>
        <zip>55125</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Independence Regional Health Center</name>
      <address>
        <city>Independence</city>
        <state>Missouri</state>
        <zip>64050</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. John's Regional Medical Center</name>
      <address>
        <city>Joplin</city>
        <state>Missouri</state>
        <zip>64804</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Truman Medical Center - Hospital Hill</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64108</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Luke's Cancer Institute at Saint Luke's Hospital</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64111</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Joseph Medical Center</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>North Kansas City Hospital</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64116</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Parvin Radiation Oncology</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64116</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CCOP - Kansas City</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64131</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kansas City Cancer Centers - South</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64131</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Medical Center</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64132</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Liberty Hospital</name>
      <address>
        <city>Liberty</city>
        <state>Missouri</state>
        <zip>64068</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Heartland Regional Medical Center</name>
      <address>
        <city>Saint Joseph</city>
        <state>Missouri</state>
        <zip>64506</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CCOP - Cancer Research for the Ozarks</name>
      <address>
        <city>Springfield</city>
        <state>Missouri</state>
        <zip>65802</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. John's Regional Health Center</name>
      <address>
        <city>Springfield</city>
        <state>Missouri</state>
        <zip>65804</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hulston Cancer Center at Cox Medical Center South</name>
      <address>
        <city>Springfield</city>
        <state>Missouri</state>
        <zip>65807</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CCOP - Montana Cancer Consortium</name>
      <address>
        <city>Billings</city>
        <state>Montana</state>
        <zip>59101</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hematology-Oncology Centers of the Northern Rockies - Billings</name>
      <address>
        <city>Billings</city>
        <state>Montana</state>
        <zip>59101</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Northern Rockies Radiation Oncology Center</name>
      <address>
        <city>Billings</city>
        <state>Montana</state>
        <zip>59101</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Vincent Healthcare Cancer Care Services</name>
      <address>
        <city>Billings</city>
        <state>Montana</state>
        <zip>59101</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Billings Clinic - Downtown</name>
      <address>
        <city>Billings</city>
        <state>Montana</state>
        <zip>59107-7000</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. James Healthcare Cancer Care</name>
      <address>
        <city>Butte</city>
        <state>Montana</state>
        <zip>59701</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Great Falls Clinic - Main Facility</name>
      <address>
        <city>Great Falls</city>
        <state>Montana</state>
        <zip>59405</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Great Falls</city>
        <state>Montana</state>
        <zip>59405</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Northern Montana Hospital</name>
      <address>
        <city>Havre</city>
        <state>Montana</state>
        <zip>59501</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Glacier Oncology, PLLC</name>
      <address>
        <city>Kalispell</city>
        <state>Montana</state>
        <zip>59901</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kalispell Medical Oncology at KRMC</name>
      <address>
        <city>Kalispell</city>
        <state>Montana</state>
        <zip>59901</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kalispell Regional Medical Center</name>
      <address>
        <city>Kalispell</city>
        <state>Montana</state>
        <zip>59901</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Community Medical Center</name>
      <address>
        <city>Missoula</city>
        <state>Montana</state>
        <zip>59801</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Guardian Oncology and Center for Wellness</name>
      <address>
        <city>Missoula</city>
        <state>Montana</state>
        <zip>59804</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Montana Cancer Specialists at Montana Cancer Center</name>
      <address>
        <city>Missoula</city>
        <state>Montana</state>
        <zip>59807-7877</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Montana Cancer Center at St. Patrick Hospital and Health Sciences Center</name>
      <address>
        <city>Missoula</city>
        <state>Montana</state>
        <zip>59807</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Good Samaritan Cancer Center at Good Samaritan Hospital</name>
      <address>
        <city>Kearney</city>
        <state>Nebraska</state>
        <zip>68848-1990</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cancer Resource Center - Lincoln</name>
      <address>
        <city>Lincoln</city>
        <state>Nebraska</state>
        <zip>68510</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CCOP - Missouri Valley Cancer Consortium</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Methodist Estabrook Cancer Center</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Immanuel Medical Center</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68122</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Alegant Health Cancer Center at Bergan Mercy Medical Center</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68124</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Creighton University Medical Center</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68131-2197</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Medical Center of Southern Nevada</name>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <zip>89102</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CCOP - Nevada Cancer Research Foundation</name>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <zip>89106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dartmouth - Hitchcock Concord</name>
      <address>
        <city>Concord</city>
        <state>New Hampshire</state>
        <zip>03301</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kingsbury Center for Cancer Care at Cheshire Medical Center</name>
      <address>
        <city>Keene</city>
        <state>New Hampshire</state>
        <zip>03431</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center</name>
      <address>
        <city>Lebanon</city>
        <state>New Hampshire</state>
        <zip>03756-0002</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Barnabas Medical Center Cancer Center</name>
      <address>
        <city>Livingston</city>
        <state>New Jersey</state>
        <zip>07039</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Frederick R. and Betty M. Smith Cancer Treatment Center</name>
      <address>
        <city>Sparta</city>
        <state>New Jersey</state>
        <zip>07871</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cancer Institute of New Jersey at Cooper - Voorhees</name>
      <address>
        <city>Voorhees</city>
        <state>New Jersey</state>
        <zip>08043</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>New York Methodist Hospital</name>
      <address>
        <city>Brooklyn</city>
        <state>New York</state>
        <zip>11215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Monter Cancer Center of the North Shore-LIJ Health System</name>
      <address>
        <city>Lake Success</city>
        <state>New York</state>
        <zip>11042</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CCOP - North Shore University Hospital</name>
      <address>
        <city>Manhasset</city>
        <state>New York</state>
        <zip>11030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Don Monti Comprehensive Cancer Center at North Shore University Hospital</name>
      <address>
        <city>Manhasset</city>
        <state>New York</state>
        <zip>11030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Long Island Jewish Medical Center</name>
      <address>
        <city>New Hyde Park</city>
        <state>New York</state>
        <zip>11040</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Memorial Sloan-Kettering Cancer Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hudson Valley Oncology Associates</name>
      <address>
        <city>Poughkeepsie</city>
        <state>New York</state>
        <zip>12601</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lipson Cancer and Blood Center at Rochester General Hospital</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14621</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mission Hospitals - Memorial Campus</name>
      <address>
        <city>Asheville</city>
        <state>North Carolina</state>
        <zip>28801</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wayne Memorial Hospital, Incorporated</name>
      <address>
        <city>Goldsboro</city>
        <state>North Carolina</state>
        <zip>27534</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wayne Radiation Oncology</name>
      <address>
        <city>Goldsboro</city>
        <state>North Carolina</state>
        <zip>27534</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rutherford Hospital</name>
      <address>
        <city>Rutherfordton</city>
        <state>North Carolina</state>
        <zip>28139</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wilmed Radiation Oncology Services</name>
      <address>
        <city>Wilson</city>
        <state>North Carolina</state>
        <zip>27893</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CCOP - MeritCare Hospital</name>
      <address>
        <city>Fargo</city>
        <state>North Dakota</state>
        <zip>58122</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MeritCare Broadway</name>
      <address>
        <city>Fargo</city>
        <state>North Dakota</state>
        <zip>58122</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>McDowell Cancer Center at Akron General Medical Center</name>
      <address>
        <city>Akron</city>
        <state>Ohio</state>
        <zip>44307</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Summa Center for Cancer Care at Akron City Hospital</name>
      <address>
        <city>Akron</city>
        <state>Ohio</state>
        <zip>44309-2090</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mary Rutan Hospital</name>
      <address>
        <city>Bellefontaine</city>
        <state>Ohio</state>
        <zip>43311</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wood County Oncology Center</name>
      <address>
        <city>Bowling Green</city>
        <state>Ohio</state>
        <zip>43402</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Aultman Cancer Center at Aultman Hospital</name>
      <address>
        <city>Canton</city>
        <state>Ohio</state>
        <zip>44710-1799</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Adena Regional Medical Center</name>
      <address>
        <city>Chillicothe</city>
        <state>Ohio</state>
        <zip>45601</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic Cancer Center at Fairview Hospital</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44111</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic Taussig Cancer Center</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Riverside Methodist Hospital Cancer Care</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43214-3998</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CCOP - Columbus</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Grant Medical Center Cancer Care</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mount Carmel Health - West Hospital</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43222</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Doctors Hospital at Ohio Health</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43228</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Grady Memorial Hospital</name>
      <address>
        <city>Delaware</city>
        <state>Ohio</state>
        <zip>43015</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic Cancer Center</name>
      <address>
        <city>Independence</city>
        <state>Ohio</state>
        <zip>44131</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fairfield Medical Center</name>
      <address>
        <city>Lancaster</city>
        <state>Ohio</state>
        <zip>43130</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lima Memorial Hospital</name>
      <address>
        <city>Lima</city>
        <state>Ohio</state>
        <zip>45804</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Strecker Cancer Center at Marietta Memorial Hospital</name>
      <address>
        <city>Marietta</city>
        <state>Ohio</state>
        <zip>45750</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Northwest Ohio Oncology Center</name>
      <address>
        <city>Maumee</city>
        <state>Ohio</state>
        <zip>43537</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Luke's Hospital</name>
      <address>
        <city>Maumee</city>
        <state>Ohio</state>
        <zip>43537</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Licking Memorial Cancer Care Program at Licking Memorial Hospital</name>
      <address>
        <city>Newark</city>
        <state>Ohio</state>
        <zip>43055</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Charles Mercy Hospital</name>
      <address>
        <city>Oregon</city>
        <state>Ohio</state>
        <zip>43616</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Toledo Clinic - Oregon</name>
      <address>
        <city>Oregon</city>
        <state>Ohio</state>
        <zip>43616</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cancer Research UK Medical Oncology Unit at Churchill Hospital &amp; Weatherall Institute of Molecular Medicine - Oxford</name>
      <address>
        <city>Salem</city>
        <state>Ohio</state>
        <zip>44460</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>North Coast Cancer Care, Incorporated</name>
      <address>
        <city>Sandusky</city>
        <state>Ohio</state>
        <zip>44870</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mercy Medical Center</name>
      <address>
        <city>Springfield</city>
        <state>Ohio</state>
        <zip>45504</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Community Hospital of Springfield and Clark County</name>
      <address>
        <city>Springfield</city>
        <state>Ohio</state>
        <zip>45505</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Flower Hospital Cancer Center</name>
      <address>
        <city>Sylvania</city>
        <state>Ohio</state>
        <zip>43560</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mercy Hospital of Tiffin</name>
      <address>
        <city>Tiffin</city>
        <state>Ohio</state>
        <zip>44883</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Toledo Hospital</name>
      <address>
        <city>Toledo</city>
        <state>Ohio</state>
        <zip>43606</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Vincent Mercy Medical Center</name>
      <address>
        <city>Toledo</city>
        <state>Ohio</state>
        <zip>43608</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical University of Ohio Cancer Center</name>
      <address>
        <city>Toledo</city>
        <state>Ohio</state>
        <zip>43614</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CCOP - Toledo Community Hospital</name>
      <address>
        <city>Toledo</city>
        <state>Ohio</state>
        <zip>43617</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Toledo Clinic, Incorporated - Main Clinic</name>
      <address>
        <city>Toledo</city>
        <state>Ohio</state>
        <zip>43623</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fulton County Health Center</name>
      <address>
        <city>Wauseon</city>
        <state>Ohio</state>
        <zip>43567</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mount Carmel St. Ann's Cancer Center</name>
      <address>
        <city>Westerville</city>
        <state>Ohio</state>
        <zip>43081</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cancer Treatment Center</name>
      <address>
        <city>Wooster</city>
        <state>Ohio</state>
        <zip>44691</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Genesis - Good Samaritan Hospital</name>
      <address>
        <city>Zanesville</city>
        <state>Ohio</state>
        <zip>43701</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oklahoma University Cancer Institute</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Natalie Warren Bryant Cancer Center at St. Francis Hospital</name>
      <address>
        <city>Tulsa</city>
        <state>Oklahoma</state>
        <zip>74136</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Willamette Valley Cancer Center - Eugene</name>
      <address>
        <city>Eugene</city>
        <state>Oregon</state>
        <zip>97401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Legacy Mount Hood Medical Center</name>
      <address>
        <city>Gresham</city>
        <state>Oregon</state>
        <zip>97030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Providence Milwaukie Hospital</name>
      <address>
        <city>Milwaukie</city>
        <state>Oregon</state>
        <zip>97222</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Legacy Good Samaritan Hospital &amp; Comprehensive Cancer Center</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97210</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Providence Cancer Center at Providence Portland Medical Center</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97213-2967</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Adventist Medical Center</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97216</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CCOP - Columbia River Oncology Program</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97225</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Providence St. Vincent Medical Center</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97225</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Legacy Emanuel Hospital and Health Center and Children's Hospital</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97227</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Salem Hospital Regional Cancer Care Services</name>
      <address>
        <city>Salem</city>
        <state>Oregon</state>
        <zip>97309-5014</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Legacy Meridian Park Hospital</name>
      <address>
        <city>Tualatin</city>
        <state>Oregon</state>
        <zip>97062</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rosenfeld Cancer Center at Abington Memorial Hospital</name>
      <address>
        <city>Abington</city>
        <state>Pennsylvania</state>
        <zip>19001</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Morgan Cancer Center at Lehigh Valley Hospital - Cedar Crest</name>
      <address>
        <city>Allentown</city>
        <state>Pennsylvania</state>
        <zip>18105</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bryn Mawr Hospital</name>
      <address>
        <city>Bryn Mawr</city>
        <state>Pennsylvania</state>
        <zip>19010</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Geisinger Cancer Institute at Geisinger Health</name>
      <address>
        <city>Danville</city>
        <state>Pennsylvania</state>
        <zip>17822-0001</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Northeast Radiation Oncology Center</name>
      <address>
        <city>Dunmore</city>
        <state>Pennsylvania</state>
        <zip>18512</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dale and Frances Hughes Cancer Center at Pocono Medical Center</name>
      <address>
        <city>East Stroudsburg</city>
        <state>Pennsylvania</state>
        <zip>18301</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Penn State Cancer Institute at Milton S. Hershey Medical Center</name>
      <address>
        <city>Hershey</city>
        <state>Pennsylvania</state>
        <zip>17033-0850</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Riddle Memorial Hospital Cancer Center</name>
      <address>
        <city>Media</city>
        <state>Pennsylvania</state>
        <zip>19063</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Upper Delaware Valley Cancer Center</name>
      <address>
        <city>Milford</city>
        <state>Pennsylvania</state>
        <zip>18337</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Intercommunity Cancer Center</name>
      <address>
        <city>Monroeville</city>
        <state>Pennsylvania</state>
        <zip>15146</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Alle-Kiski Medical Center</name>
      <address>
        <city>Natrona Heights</city>
        <state>Pennsylvania</state>
        <zip>15065</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cancer Center of Paoli Memorial Hospital</name>
      <address>
        <city>Paoli</city>
        <state>Pennsylvania</state>
        <zip>19301-1792</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kimmel Cancer Center at Thomas Jefferson University - Philadelphia</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107-5541</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fox Chase Cancer Center - Philadelphia</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19111-2497</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Frankford Hospital Cancer Center - Torresdale Campus</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Allegheny Cancer Center at Allegheny General Hospital</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15212</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center</name>
      <address>
        <city>Reading</city>
        <state>Pennsylvania</state>
        <zip>19612-6052</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Somerset Oncology Center</name>
      <address>
        <city>Somerset</city>
        <state>Pennsylvania</state>
        <zip>15501</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Frank M. and Dorothea Henry Cancer Center at Geisinger Wyoming Valley Medical Center</name>
      <address>
        <city>Wilkes-Barre</city>
        <state>Pennsylvania</state>
        <zip>18711</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CCOP - Main Line Health</name>
      <address>
        <city>Wynnewood</city>
        <state>Pennsylvania</state>
        <zip>19096</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lankenau Cancer Center at Lankenau Hospital</name>
      <address>
        <city>Wynnewood</city>
        <state>Pennsylvania</state>
        <zip>19096</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>AnMed Cancer Center</name>
      <address>
        <city>Anderson</city>
        <state>South Carolina</state>
        <zip>29621</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hollings Cancer Center at Medical University of South Carolina</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CCOP - Upstate Carolina</name>
      <address>
        <city>Spartanburg</city>
        <state>South Carolina</state>
        <zip>29303</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gibbs Regional Cancer Center at Spartanburg Regional Medical Center</name>
      <address>
        <city>Spartanburg</city>
        <state>South Carolina</state>
        <zip>29303</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rapid City Regional Hospital</name>
      <address>
        <city>Rapid City</city>
        <state>South Dakota</state>
        <zip>57701</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Avera Cancer Institute</name>
      <address>
        <city>Sioux Falls</city>
        <state>South Dakota</state>
        <zip>57105</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical X-Ray Center, PC</name>
      <address>
        <city>Sioux Falls</city>
        <state>South Dakota</state>
        <zip>57105</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanford Cancer Center at Sanford USD Medical Center</name>
      <address>
        <city>Sioux Falls</city>
        <state>South Dakota</state>
        <zip>57117-5039</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Thompson Cancer Survival Center West</name>
      <address>
        <city>Knoxville</city>
        <state>Tennessee</state>
        <zip>37392</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Thompson Cancer Survival Center</name>
      <address>
        <city>Knoxville</city>
        <state>Tennessee</state>
        <zip>37916</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Thompson Cancer Survival Center at Methodist</name>
      <address>
        <city>Oak Ridge</city>
        <state>Tennessee</state>
        <zip>37830</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical City Dallas Hospital</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75230</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Texas Oncology, PA at Texas Cancer Center Dallas Southwest</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75237</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klabzuba Cancer Center at Harris Methodist Fort Worth Hospital</name>
      <address>
        <city>Fort Worth</city>
        <state>Texas</state>
        <zip>76104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>M. D. Anderson Cancer Center at University of Texas</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030-4009</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Joe Arrington Cancer Research and Treatment Center</name>
      <address>
        <city>Lubbock</city>
        <state>Texas</state>
        <zip>79410-1894</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Texas Oncology, PA at Texas Cancer Center - Sherman</name>
      <address>
        <city>Sherman</city>
        <state>Texas</state>
        <zip>75090</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Texas Oncology, PA at Texas Oncology Cancer Center Sugar Land</name>
      <address>
        <city>Sugar Land</city>
        <state>Texas</state>
        <zip>77479</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>American Fork Hospital</name>
      <address>
        <city>American Fork</city>
        <state>Utah</state>
        <zip>84003</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sandra L. Maxwell Cancer Center</name>
      <address>
        <city>Cedar City</city>
        <state>Utah</state>
        <zip>84720</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Jon and Karen Huntsman Cancer Center at Intermountain Medical Center</name>
      <address>
        <city>Murray</city>
        <state>Utah</state>
        <zip>84157</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Val and Ann Browning Cancer Center at McKay-Dee Hospital Center</name>
      <address>
        <city>Ogden</city>
        <state>Utah</state>
        <zip>84403</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Utah Valley Regional Medical Center - Provo</name>
      <address>
        <city>Provo</city>
        <state>Utah</state>
        <zip>84604</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dixie Regional Medical Center - East Campus</name>
      <address>
        <city>Saint George</city>
        <state>Utah</state>
        <zip>84770</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>LDS Hospital</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Utah Cancer Specialists at UCS Cancer Center</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Huntsman Cancer Institute at University of Utah</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84112</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fletcher Allen Health Care - University Health Center Campus</name>
      <address>
        <city>Burlington</city>
        <state>Vermont</state>
        <zip>05401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Norris Cotton Cancer Center - North</name>
      <address>
        <city>Saint Johnsbury</city>
        <state>Vermont</state>
        <zip>05819</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fredericksburg Oncology, Incorporated</name>
      <address>
        <city>Fredericksburg</city>
        <state>Virginia</state>
        <zip>22401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sentara Cancer Institute at Sentara Norfolk General Hospital</name>
      <address>
        <city>Norfolk</city>
        <state>Virginia</state>
        <zip>23507</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Virginia Commonwealth University Massey Cancer Center</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23298-0037</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Joseph Cancer Center</name>
      <address>
        <city>Bellingham</city>
        <state>Washington</state>
        <zip>98225</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Francis Hospital</name>
      <address>
        <city>Federal Way</city>
        <state>Washington</state>
        <zip>98003</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cascade Cancer Center at Evergreen Hospital Medical Center</name>
      <address>
        <city>Kirkland</city>
        <state>Washington</state>
        <zip>98033</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CCOP - Virginia Mason Research Center</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98101</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Cancer Center at University of Washington Medical Center</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98195-6043</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Southwest Washington Medical Center Cancer Center</name>
      <address>
        <city>Vancouver</city>
        <state>Washington</state>
        <zip>98668</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>North Star Lodge Cancer Center at Yakima Valley Memorial Hospital</name>
      <address>
        <city>Yakima</city>
        <state>Washington</state>
        <zip>98902</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Theda Care Cancer Institute</name>
      <address>
        <city>Appleton</city>
        <state>Wisconsin</state>
        <zip>54911</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Green Bay Oncology, Limited at St. Vincent Hospital Regional Cancer Center</name>
      <address>
        <city>Green Bay</city>
        <state>Wisconsin</state>
        <zip>54301-3526</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Green Bay Oncology, Limited at St. Mary's Hospital</name>
      <address>
        <city>Green Bay</city>
        <state>Wisconsin</state>
        <zip>54303</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Mary's Hospital Medical Center - Green Bay</name>
      <address>
        <city>Green Bay</city>
        <state>Wisconsin</state>
        <zip>54303</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Vincent Hospital Regional Cancer Center</name>
      <address>
        <city>Green Bay</city>
        <state>Wisconsin</state>
        <zip>54307-3508</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gundersen Lutheran Center for Cancer and Blood</name>
      <address>
        <city>La Crosse</city>
        <state>Wisconsin</state>
        <zip>54601</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Wisconsin Paul P. Carbone Comprehensive Cancer Center</name>
      <address>
        <city>Madison</city>
        <state>Wisconsin</state>
        <zip>53792-6164</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bay Area Cancer Care Center at Bay Area Medical Center</name>
      <address>
        <city>Marinette</city>
        <state>Wisconsin</state>
        <zip>54143</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Community Memorial Hospital Cancer Care Center</name>
      <address>
        <city>Menomonee Falls</city>
        <state>Wisconsin</state>
        <zip>53051</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Regional Cancer Center at Oconomowoc Memorial Hospital</name>
      <address>
        <city>Oconomowoc</city>
        <state>Wisconsin</state>
        <zip>53066</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Green Bay Oncology, Limited - Oconto Falls</name>
      <address>
        <city>Oconto Falls</city>
        <state>Wisconsin</state>
        <zip>54154</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Door County Cancer Center at Door County Memorial Hospital</name>
      <address>
        <city>Sturgeon Bay</city>
        <state>Wisconsin</state>
        <zip>54235-1495</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Green Bay Oncology, Limited - Sturgeon Bay</name>
      <address>
        <city>Sturgeon Bay</city>
        <state>Wisconsin</state>
        <zip>54235</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Waukesha Memorial Hospital Regional Cancer Center</name>
      <address>
        <city>Waukesha</city>
        <state>Wisconsin</state>
        <zip>53188</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tom Baker Cancer Centre - Calgary</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <zip>T2N 4N2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CancerCare Manitoba</name>
      <address>
        <city>Winnipeg</city>
        <state>Manitoba</state>
        <zip>R3E 0V9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint John Regional Hospital</name>
      <address>
        <city>Saint John</city>
        <state>New Brunswick</state>
        <zip>E2L 4L2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Margaret and Charles Juravinski Cancer Centre</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8V 5C2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ottawa Hospital Regional Cancer Centre - General Campus</name>
      <address>
        <city>Ottawa</city>
        <state>Ontario</state>
        <zip>K1Y 4K7</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cancer Care Program at Thunder Bay Regional Health Sciences</name>
      <address>
        <city>Thunder Bay</city>
        <state>Ontario</state>
        <zip>P7B 6V4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Princess Margaret Hospital</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5G 2M9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>McGill Cancer Centre at McGill University</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H2W 1S6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire de Quebec</name>
      <address>
        <city>Quebec City</city>
        <state>Quebec</state>
        <zip>G1R 2J6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Allan Blair Cancer Centre at Pasqua Hospital</name>
      <address>
        <city>Regina</city>
        <state>Saskatchewan</state>
        <zip>S4T 7T1</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2013.49.6968</url>
    <description>Study results manuscript in Journal of Clinical Oncology</description>
  </link>
  <results_reference>
    <citation>Aldape KD, Wang M, Sulman EP, et al.: RTOG 0525: molecular correlates from a randomized phase III trial of newly diagnosed glioblastoma. [Abstract] J Clin Oncol 29 (Suppl 15): A-LBA2000, 2011.</citation>
  </results_reference>
  <results_reference>
    <citation>Armstrong TS, Wefel JS, Wang M, et al.: Clinical utility of neurocognitive function (NCF), quality of life (QOL), and symptom assessment as prognostic factors for survival and measures of treatment effects on RTOG 0525. [Abstract] J Clin Oncol 29 (Suppl 15): A-2016, 2011.</citation>
  </results_reference>
  <results_reference>
    <citation>Gilbert MR, Wang M, Aldape KD, Stupp R, Hegi ME, Jaeckle KA, Armstrong TS, Wefel JS, Won M, Blumenthal DT, Mahajan A, Schultz CJ, Erridge S, Baumert B, Hopkins KI, Tzuk-Shina T, Brown PD, Chakravarti A, Curran WJ Jr, Mehta MP. Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial. J Clin Oncol. 2013 Nov 10;31(32):4085-91. doi: 10.1200/JCO.2013.49.6968. Epub 2013 Oct 7.</citation>
    <PMID>24101040</PMID>
  </results_reference>
  <results_reference>
    <citation>Wang M, Dignam J, Won M, et al.: Variation over time and interdependence between disease progression and death among patients with glioblastoma (GBM) on RTOG 0525. [Abstract] J Clin Oncol 29 (Suppl 15): A-2017, 2011.</citation>
  </results_reference>
  <results_reference>
    <citation>Aldape KD, Jones G, Wang M, et al.: MGMT methylation testing in RTOG 0525: A phase III trial of newly diagnosed glioblastoma. [Abstract] J Clin Oncol 27 (Suppl 15): A-2051, 2009.</citation>
  </results_reference>
  <verification_date>December 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 15, 2006</study_first_submitted>
  <study_first_submitted_qc>March 15, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 17, 2006</study_first_posted>
  <results_first_submitted>March 28, 2014</results_first_submitted>
  <results_first_submitted_qc>March 28, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">April 30, 2014</results_first_posted>
  <last_update_submitted>December 30, 2016</last_update_submitted>
  <last_update_submitted_qc>December 30, 2016</last_update_submitted_qc>
  <last_update_posted type="Actual">February 17, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>adult glioblastoma</keyword>
  <keyword>adult giant cell glioblastoma</keyword>
  <keyword>adult gliosarcoma</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glioblastoma</mesh_term>
    <mesh_term>Gliosarcoma</mesh_term>
    <mesh_term>Nervous System Neoplasms</mesh_term>
    <mesh_term>Central Nervous System Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Temozolomide</mesh_term>
    <mesh_term>Dacarbazine</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>No Adjuvant TMZ (Not Randomized)</title>
          <description>Concurrent radiation therapy (RT) with concurrent temozolomide (75 mg/m2) up to 49 doses. Not randomized to either adjuvant TMZ arm.</description>
        </group>
        <group group_id="P2">
          <title>Conventional Adjuvant TMZ</title>
          <description>Concurrent radiation therapy with concurrent temozolomide (75 mg/m2) up to 49 doses. Starting four weeks after completion of RT, 100mg/m2 adjuvant temozolomide days 1 to 5 of 28 day cycle.</description>
        </group>
        <group group_id="P3">
          <title>Dose-dense Adjuvant TMZ</title>
          <description>Concurrent radiation therapy (RT) with concurrent temozolomide (75 mg/m2) up to 49 doses. Starting four weeks after completion of RT, 75mg/m2 adjuvant temozolomide days 1-21 of 28 day cycle.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Registration</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="1173">All patients were registered to concomitant treatment; randomized after completing this treatment.</participants>
                <participants group_id="P2" count="0">Patients were not randomized to adjuvant TMZ until after completion of concomitant treatment.</participants>
                <participants group_id="P3" count="0">Patients were not randomized to adjuvant TMZ until after completion of concomitant treatment.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1125">Patients determined to be ineligible after registration were excluded.</participants>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="48"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Ineligible</title>
              <participants_list>
                <participants group_id="P1" count="48"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Concomitant Radiation Therapy and TMZ</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="1125">All patients were registered to concomitant treatment; randomized after completing this treatment.</participants>
                <participants group_id="P2" count="0">Patients were not randomized to adjuvant TMZ until after completion of concomitant treatment.</participants>
                <participants group_id="P3" count="0">Patients were not randomized to adjuvant TMZ until after completion of concomitant treatment.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="833">These patients successfully completed concomitant treatment and met requirements for randomization.</participants>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="292"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Ineligible due to insufficient tissue</title>
              <participants_list>
                <participants group_id="P1" count="144"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Disease progression</title>
              <participants_list>
                <participants group_id="P1" count="48"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Patient refusal</title>
              <participants_list>
                <participants group_id="P1" count="19"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="18"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Physician preference</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Toxicity</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Other complicating disease</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Other, not otherwise specified</title>
              <participants_list>
                <participants group_id="P1" count="37"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Randomization to Adjuvant TMZ Arm</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="0">Patients who met requirements were randomized to an adjuvant TMZ arm after concomitant treatment.</participants>
                <participants group_id="P2" count="411">Patients who met requirements were randomized to an adjuvant TMZ arm after concomitant treatment.</participants>
                <participants group_id="P3" count="422">Patients who met requirements were randomized to an adjuvant TMZ arm after concomitant treatment.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="411">Subjects contributing data to the primary analysis are considered to have completed the study.</participants>
                <participants group_id="P3" count="420">Subjects contributing data to the primary analysis are considered to have completed the study</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>No follow-up collected</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Eligible patients who were randomized.</population>
      <group_list>
        <group group_id="B1">
          <title>No Adjuvant TMZ (Not Randomized )</title>
          <description>Concurrent radiation therapy (RT) with concurrent temozolomide (75 mg/m2) up to 49 doses. Not randomized to either adjuvant TMZ arm.</description>
        </group>
        <group group_id="B2">
          <title>Conventional Adjuvant TMZ</title>
          <description>Concurrent radiation therapy with concurrent temozolomide (75 mg/m2) up to 49 doses. Starting four weeks after completion of RT, 100mg/m2 adjuvant temozolomide days 1 to 5 of 28 day cycle.</description>
        </group>
        <group group_id="B3">
          <title>Dose-dense Adjuvant TMZ</title>
          <description>Concurrent radiation therapy (RT) with concurrent temozolomide (75 mg/m2) up to 49 doses. Starting four weeks after completion of RT, 75mg/m2 adjuvant temozolomide days 1-21 of 28 day cycle.</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="292"/>
            <count group_id="B2" value="411"/>
            <count group_id="B3" value="422"/>
            <count group_id="B4" value="1125"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="60.5" lower_limit="22" upper_limit="87"/>
                    <measurement group_id="B2" value="57" lower_limit="22" upper_limit="84"/>
                    <measurement group_id="B3" value="58" lower_limit="21" upper_limit="84"/>
                    <measurement group_id="B4" value="58" lower_limit="21" upper_limit="87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="126"/>
                    <measurement group_id="B2" value="172"/>
                    <measurement group_id="B3" value="185"/>
                    <measurement group_id="B4" value="483"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="166"/>
                    <measurement group_id="B2" value="239"/>
                    <measurement group_id="B3" value="237"/>
                    <measurement group_id="B4" value="642"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Overall Survival (OS)</title>
        <time_frame>From randomization to date of death or last follow-up. Analysis occurs after 647 deaths have been reported.</time_frame>
        <population>Eligible patients who were randomized to an adjuvant temozolomide arm and contributed follow-up data.</population>
        <group_list>
          <group group_id="O1">
            <title>Conventional Adjuvant TMZ</title>
            <description>Concurrent radiation therapy with concurrent temozolomide (75 mg/m2) up to 49 doses. Starting four weeks after completion of RT, 100mg/m2 adjuvant temozolomide days 1 to 5 of 28 day cycle.</description>
          </group>
          <group group_id="O2">
            <title>Dose-dense Adjuvant TMZ</title>
            <description>Concurrent radiation therapy (RT) with concurrent temozolomide (75 mg/m2) up to 49 doses. Starting four weeks after completion of RT, 75mg/m2 adjuvant temozolomide days 1-21 of 28 day cycle.</description>
          </group>
        </group_list>
        <measure>
          <title>Overall Survival (OS)</title>
          <population>Eligible patients who were randomized to an adjuvant temozolomide arm and contributed follow-up data.</population>
          <units>months</units>
          <param>Median</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="411"/>
                <count group_id="O2" value="420"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.6" lower_limit="14.9" upper_limit="18.0"/>
                    <measurement group_id="O2" value="14.9" lower_limit="13.7" upper_limit="16.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>This study was looking for a 20% reduction in hazard rate: null hypothesis (conventional arm): MST (median survival time) = 14.0 mo.; alternative hypothesis (dose-dense arm): MST= 17.5 mo. A one-sided log-rank test at a significance level of 0.025 would have 80% power to detect this difference with a sample size of 750 patients (647 deaths were required for the final analysis).</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.63</p_value>
            <p_value_desc>One-sided</p_value_desc>
            <method>Log Rank</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>1.03</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.88</ci_lower_limit>
            <ci_upper_limit>1.20</ci_upper_limit>
            <estimate_desc>Hazard ratio: denominator = conventional arm, numerator = dose-dense arm.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Progression-free Survival (PFS)</title>
        <time_frame>From randomization to date of progression, death or last follow-up. Analysis occurs after 647 deaths have been reported.</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Comparison of OS and PFS in Patients With Unmethylated MGMT</title>
        <time_frame>From randomization to date of progression, death or last follow-up. Analysis occurs after 647 deaths have been reported.</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Comparison of OS and PFS in Patients With Methylated MGMT</title>
        <time_frame>From randomization to date of progression, death or last follow-up. Analysis occurs after 647 deaths have been reported.</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Correlation of Tumor MGMT Gene Methylation Status With Treatment Response</title>
        <time_frame>From randomization to date of progression, death or last follow-up. Analysis occurs after 647 deaths have been reported.</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Toxicity</title>
        <time_frame>From start of treatment to end of follow-up</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Correlation of PFS With OS at 6 Months</title>
        <time_frame>From randomization to date of progression, death or last follow-up. Analysis occurs after 647 deaths have been reported.</time_frame>
      </outcome>
    </outcome_list>

    <reported_events>
      <desc>Subjects experiencing more than one of a given SAE (serious adverse event) are counted only once for that SAE. The same methodology was applied for non-SAE adverse events (AE). Number of participants at risk is the number of eligible participants with adverse event information.</desc>
      <group_list>
        <group group_id="E1">
          <title>No Adjuvant TMZ (Not Randomized)</title>
          <description>Concurrent radiation therapy (RT) with concurrent temozolomide (75 mg/m2) up to 49 doses. Not randomized to either adjuvant TMZ arm.
Concurrent temozolomide: Daily oral temozolomide (75 mg/m2) up to 49 doses.
Concurrent radiation therapy: 60 Gy in 2 Gy fractions</description>
        </group>
        <group group_id="E2">
          <title>Conventional Adjuvant TMZ</title>
          <description>Concurrent radiation therapy with concurrent temozolomide (75 mg/m2) up to 49 doses. Starting four weeks after completion of RT, 100mg/m2 adjuvant temozolomide days 1 to 5 of 28 day cycle.
Concurrent temozolomide: Daily oral temozolomide (75 mg/m2) up to 49 doses.
Concurrent radiation therapy: 60 Gy in 2 Gy fractions
100mg/m2 adjuvant temozolomide days 1 to 5 of 28 day cycle: Oral temozolomide on days 1-5 of a 28-day cycle. Dose starts at 150mg/m2 for first cycle, increases to 200mg/m2 for subsequent cycles if no unacceptable toxicity. Treatment repeats every 28 days for up to 6 courses in the absence of disease progression or unacceptable toxicity. Patients with responding disease may receive up to 6 more courses of temozolomide.</description>
        </group>
        <group group_id="E3">
          <title>Dose-dense Adjuvant TMZ</title>
          <description>Concurrent radiation therapy (RT) with concurrent temozolomide (75 mg/m2) up to 49 doses. Starting four weeks after completion of RT, 75mg/m2 adjuvant temozolomide days 1-21 of 28 day cycle.
Concurrent temozolomide: Daily oral temozolomide (75 mg/m2) up to 49 doses.
Concurrent radiation therapy: 60 Gy in 2 Gy fractions
75mg/m2 adjuvant temozolomide days 1-21 of 28 day cycle: Oral temozolomide on days 1-21 of a 28-day cycle. Dose starts at 75mg/m2 for first cycle, increases to 100mg/m2 for subsequent cycles if no unacceptable toxicity. Treatment repeats every 28 days for up to 6 courses in the absence of disease progression or unacceptable toxicity. Patients with responding disease may receive up to 6 more courses of temozolomide.</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>CTCAE (2.0)</default_vocab>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="100" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="128" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="139" subjects_at_risk="420"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Blood/bone marrow - Other:</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Bone marrow depression NOS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Febrile neutropenia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Haemolysis NOS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Hemoglobin</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Thrombotic microangiopathy NOS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Atrial fibrillation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Atrial flutter</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Atrial tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Cardiac General - Other:</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Myocardial ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Pericardial effusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Sinus bradycardia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Sinus tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Supraventricular extrasystoles</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Cushingoid</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Hypothyroidism</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Diplopia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Extraocular muscle disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Ocular/visual - Other:</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Photopsia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Retinal detachment</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Vision blurred</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal pain NOS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Colitis NOS</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Colonic perforation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Diarrhoea NOS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Dysphagia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Enteritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Gastritis NOS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Gastrointestinal - Other:</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="10" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Oseophagitis NOS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Pancreatitis NOS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Radiation mucositis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Rectal hemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Small intestinal stricture NOS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Vomiting NOS</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="420"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Constitutional Symptoms - Other:</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Death NOS</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Disease progression NOS</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Edema: head and neck:</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Edema: limb:</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="10" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Gait abnormal NOS</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Influenza-like illness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Multi-organ failure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Pain - Other:</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Pain NOS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Rigors</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Sudden death</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Cholecystitis NOS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Gallbladder pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Hepatic failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Allergy/immunology - Other:</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Cytokine release syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Hypersensitivity NOS</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="420"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Abdominal infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Bone infection NOS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Bronchitis NOS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Encephalitis NOS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Eye infection NOS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Infection - Other:</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Infection with Grade 3 or 4 neutrophils (ANC &lt;1.0 x 10e9/L): Biliary tree</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Infection with Grade 3 or 4 neutrophils (ANC &lt;1.0 x 10e9/L): Bladder (urinary)</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Infection with Grade 3 or 4 neutrophils (ANC &lt;1.0 x 10e9/L): Bronchus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Infection with Grade 3 or 4 neutrophils (ANC &lt;1.0 x 10e9/L): Kidney</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Infection with Grade 3 or 4 neutrophils (ANC &lt;1.0 x 10e9/L): Lung (pneumonia)</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Infection with Grade 3 or 4 neutrophils (ANC &lt;1.0 x 10e9/L): Meninges (meningitis)</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Infection with Grade 3 or 4 neutrophils (ANC &lt;1.0 x 10e9/L): Rectum</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Infection with Grade 3 or 4 neutrophils (ANC &lt;1.0 x 10e9/L): Soft tissue NOS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Infection with normal ANC or Grade 1 or 2 neutrophils: Blood</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Infection with normal ANC or Grade 1 or 2 neutrophils: Esophagus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Infection with normal ANC or Grade 1 or 2 neutrophils: Nerve-peripheral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Infection with normal ANC or Grade 1 or 2 neutrophils: Wound</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Infection with unknown ANC: Lung (pneumonia)</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Infection with unknown ANC: Meninges (meningitis)</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Infection with unknown ANC: Skin (cellulitis)</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Infectous meningitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Opportunisitic infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Pneumonia NOS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Sinusitis NOS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Skin infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Urinary tract infection NOS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Wound infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="420"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Fracture NOS</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Radiation recall syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Vascular access NOS complication</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Alanine aminotransferase increased</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Aspartate aminotransferase increased</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Blood alkaline phosphatase increased</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Blood amylase increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Blood bilirubin increased</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Blood creatinine increased</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>CD4 lymphocytes decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Gamma-glutamyltransferase increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Inappropriate antidiuretic hormone secretion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Leukopenia NOS</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="15" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="14" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Lipase increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Lymphopenia</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="23" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Metabolic/laboratory - Other:</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Neutrophil count</sub_title>
                <counts group_id="E1" subjects_affected="19" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="15" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="11" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Platelet count decreased</sub_title>
                <counts group_id="E1" subjects_affected="33" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="20" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="16" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Prothrombin time prolonged</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Troponin I increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Weight decreased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Acidosis NOS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Alkalosis NOS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Anorexia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Hyperglycaemia NOS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Hyperkalaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Hypoalbuminemia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Hypocalcemia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Hypoglycemia NOS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Hypokalemia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Hypomagnesemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Hyponatremia</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Chest wall pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Muscle weakness NOS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Muscle weakness, generalized or specific area (not due to neuropathy): Extremity-lower</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Muscle weakness, generalized or specific area (not due to neuropathy): Extremity-upper</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Muscle weakness, generalized or specific area (not due to neuropathy): Left-sided</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Muscle weakness, generalized or specific area (not due to neuropathy): Right-sided</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Musculoskeletal/soft tissue - Other:</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Neck pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Pain in extremity</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="420"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Ataxia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>CNS necrosis/cystic progression:</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Cerebral ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Cerebrospinal fluid leak</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Cognitive disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Convulsions NOS</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="20" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="24" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Depressed level of consciousness</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Diaphragmatic paralysis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Dysgeusia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Extrapyramidal disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Hemorrhagic stroke</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Hydrocephalus acquired</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Hyperreflexia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Memory impairment</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Mental status changes</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Muscle weakness, generalized or specific area (not due to neuropathy): Facial</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Neuralgia NOS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Neurology - Other:</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Neuropathy: cranial: CN VIII Hearing and balance</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Peripheral motor neuropathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Peripheral sensory neuropathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Speech disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Syncope vasovagal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Tremor</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Agitation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Anxiety</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Confusional state</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Insomnia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Personality change</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Psychosis aggravated</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Cystitis NOS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Renal failure NOS</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Urinary incontinence</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Scrotal pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Aspiration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Hypoxia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Nasal cavity/paranasal sinus reactions:</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Pleural effusion</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Pneumonitis NOS</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Pulmonary/upper respiratory - Other:</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Respiratory tract hemorrhage NOS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Acne NOS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Dermatitis exfoliative NOS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Pain of skin</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Petechiae</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Hematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Hypotension NOS</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="14" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="15" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="19" subjects_at_risk="420"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_vocab>CTCAE (2.0)</default_vocab>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="221" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="376" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="393" subjects_at_risk="420"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Blood/bone marrow - Other:</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="12" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Bone marrow depression NOS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Febrile neutropenia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Haemolysis NOS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Hemoglobin</sub_title>
                <counts group_id="E1" subjects_affected="69" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="138" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="170" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Lymphatics - Other:</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Spleen disorder NOS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Thrombotic microangiopathy NOS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Angina pectoris</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Arrhythmia NOS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Atrial fibrillation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Cardiac General - Other:</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Left ventricular failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Myocardial ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Palpitations</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Pericardial effusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Sinus bradycardia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Sinus tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Supraventricular tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Ventricular fibrillation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Ventricular tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Auditory/ear - Other:</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="14" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="11" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Ear pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Hearing disability</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Hearing impaired</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="26" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="19" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Otitis externa NOS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="10" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Otitis media serous NOS</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Pain: External ear</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Tinnitus</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="11" subjects_at_risk="420"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Adrenal insufficiency NOS</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Cushingoid</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="15" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="14" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Endocrine - Other:</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Hypothyroidism</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Thyrotoxicosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Cataract</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Conjunctivitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Diplopia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Dry eye NOS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Extraocular muscle disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Eye pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Eyelid function disorder NOS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Glaucoma NOS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Lacrimation increased</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="11" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Muscle weakness, generalized or specific area (not due to neuropathy): Ocular</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Ocular/visual - Other:</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="34" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="27" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Optic disc disorder NOS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Optic nerve disorder NOS</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="13" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="12" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Photophobia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Photopsia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Proptosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Retinal detachment</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Uveitis NOS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Vision blurred</sub_title>
                <counts group_id="E1" subjects_affected="20" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="44" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="53" subjects_at_risk="420"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal distention</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Abdominal pain NOS</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="16" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="23" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Anal discomfort</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Anal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Caecitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Colitis NOS</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Colonic obstruction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" subjects_affected="59" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="133" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="128" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Diarrhoea NOS</sub_title>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="48" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="71" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Dry mouth</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="22" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="26" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Dyspepsia</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="30" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="31" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Dysphagia</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="13" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Enteritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Esophageal pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Esophageal ulcer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Faecal incontinence</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Flatulence</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Gastric ulcer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Gastritis NOS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Gastrointestinal - Other:</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Gastrointestinal pain NOS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Gingival pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Hemorrhoidal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Hemorrhoids</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Ileus paralytic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Lip pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Lower gastrointestinal hemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Mouth haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Mucositis/stomatitis (clinical exam): Anus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" subjects_affected="79" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="223" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="226" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Oral pain</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Oseophagitis NOS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Pain: Peritoneum</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Pancreatic hemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Pancreatitis NOS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Peridontal disorder NOS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Proctalgia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Radiation mucositis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Rectal hemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Salivary gland disorder NOS</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Stomach discomfort</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Stomatitis</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="19" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="24" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Stricture/stenosis (including anastomotic), GI: Pancreas/pancreatic duct</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Tooth disorder NOS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Toothache</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Vomiting NOS</sub_title>
                <counts group_id="E1" subjects_affected="32" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="111" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="116" subjects_at_risk="420"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="10" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Constitutional Symptoms - Other:</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Death NOS</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Disease progression NOS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Edema: head and neck:</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="14" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="27" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Edema: limb:</sub_title>
                <counts group_id="E1" subjects_affected="18" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="47" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="54" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Edema: trunk/genital:</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Edema: viscera:</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Facial pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" subjects_affected="136" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="288" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="317" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Gait abnormal NOS</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="14" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="13" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Influenza-like illness</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Injection site reaction NOS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Irritability</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Pain - Other:</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="27" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="23" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Pain NOS</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="25" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="25" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Rigors</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="14" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Sudden death</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Cholecystitis NOS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Gallbladder pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Hepatobiliary/pancreas - Other:</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="420"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Allergy/immunology - Other:</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Hypersensitivity NOS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="420"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Abdominal infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Adenoviral hepatitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Ano-rectal infection NOS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Bladder infection NOS</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Bone infection NOS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Bronchitis NOS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Clostridial infection NOS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Ear infection NOS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Encephalitis NOS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Eye infection NOS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Genital infection NOS, female</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Gingival infection</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Infection - Other:</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="13" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="16" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Infection with Grade 3 or 4 neutrophils (ANC &lt;1.0 x 10e9/L): Bladder (urinary)</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Infection with Grade 3 or 4 neutrophils (ANC &lt;1.0 x 10e9/L): Brain (encephalitis, infectious)</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Infection with Grade 3 or 4 neutrophils (ANC &lt;1.0 x 10e9/L): Conjunctiva</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Infection with Grade 3 or 4 neutrophils (ANC &lt;1.0 x 10e9/L): External ear (otitis externa)</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Infection with Grade 3 or 4 neutrophils (ANC &lt;1.0 x 10e9/L): Gallbladder (cholecystitis)</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Infection with Grade 3 or 4 neutrophils (ANC &lt;1.0 x 10e9/L): Lung (pneumonia)</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Infection with Grade 3 or 4 neutrophils (ANC &lt;1.0 x 10e9/L): Meninges (meningitis)</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Infection with Grade 3 or 4 neutrophils (ANC &lt;1.0 x 10e9/L): Nose</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Infection with Grade 3 or 4 neutrophils (ANC &lt;1.0 x 10e9/L): Oral cavity-gums (gingivitis)</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Infection with Grade 3 or 4 neutrophils (ANC &lt;1.0 x 10e9/L): Paranasal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Infection with Grade 3 or 4 neutrophils (ANC &lt;1.0 x 10e9/L): Soft tissue NOS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Infection with Grade 3 or 4 neutrophils (ANC &lt;1.0 x 10e9/L): Upper airway NOS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Infection with Grade 3 or 4 neutrophils (ANC &lt;1.0 x 10e9/L): Urinary tract NOS</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Infection with Grade 3 or 4 neutrophils (ANC &lt;1.0 x 10e9/L): Vagina</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Infection with Grade 3 or 4 neutrophils (ANC &lt;1.0 x 10e9/L): Wound</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Infection with normal ANC or Grade 1 or 2 neutrophils: Appendix</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Infection with normal ANC or Grade 1 or 2 neutrophils: Artery</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Infection with normal ANC or Grade 1 or 2 neutrophils: Blood</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Infection with normal ANC or Grade 1 or 2 neutrophils: Colon</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Infection with normal ANC or Grade 1 or 2 neutrophils: Conjunctiva</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Infection with normal ANC or Grade 1 or 2 neutrophils: Esophagus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Infection with normal ANC or Grade 1 or 2 neutrophils: External ear (otitis externa)</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Infection with normal ANC or Grade 1 or 2 neutrophils: Lip/perioral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Infection with normal ANC or Grade 1 or 2 neutrophils: Nerve-peripheral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Infection with normal ANC or Grade 1 or 2 neutrophils: Paranasal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Infection with normal ANC or Grade 1 or 2 neutrophils: Upper aerodigestive NOS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Infection with normal ANC or Grade 1 or 2 neutrophils: Wound</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Infection with unknown ANC: Bladder (urinary)</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Infection with unknown ANC: Brain (encephalitis, infectious)</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Infection with unknown ANC: Bronchus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Infection with unknown ANC: Esophagus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Infection with unknown ANC: Lip/perioral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Infection with unknown ANC: Lung (pneumonia)</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Infection with unknown ANC: Oral cavity-gums (gingivitis)</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Infection with unknown ANC: Sinus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Infection with unknown ANC: Skin (cellulitis)</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Infection with unknown ANC: Ungual (nails)</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Infection with unknown ANC: Upper airway NOS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Infection with unknown ANC: Urinary tract NOS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Infectous meningitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Nasopharyngitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Opportunisitic infection</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Otitis media NOS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Pharyngitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Pneumonia NOS</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Respiratory tract infection NOS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="19" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Rhinitis infective</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Sepsis NOS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Sinusitis NOS</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Skin infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Soft tissue infection NOS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Tooth infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Urinary tract infection NOS</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Vaginal infection NOS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Wound infection</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="420"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Burn:</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Culture wound negative</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Dermatitis radiation NOS</sub_title>
                <counts group_id="E1" subjects_affected="43" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="96" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="103" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Ecchymosis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="13" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Fracture NOS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Intra-operative injury: Appendix</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Intra-operative injury: Thoracic duct</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Prolapse of stoma, GI:</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Radiation recall syndrome</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="20" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="26" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Vascular access NOS complication</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Vessel injury-artery: Other NOS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Activated partial thromboplastin time prolonged</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Alanine aminotransferase increased</sub_title>
                <counts group_id="E1" subjects_affected="42" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="100" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="109" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Aspartate aminotransferase increased</sub_title>
                <counts group_id="E1" subjects_affected="22" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="64" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="70" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Blood alkaline phosphatase increased</sub_title>
                <counts group_id="E1" subjects_affected="17" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="45" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="49" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Blood amylase increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Blood bilirubin increased</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="16" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="20" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Blood creatine phosphokinase increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Blood creatinine increased</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="24" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="32" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Blood human chorionic gonadotropin abnormal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>CD4 lymphocytes decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="13" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="32" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Coagulopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Gamma-glutamyltransferase increased</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="18" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="19" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Haptoglobin</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Hypercholesterolaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Leukopenia NOS</sub_title>
                <counts group_id="E1" subjects_affected="44" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="150" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="190" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Lipase increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Lymphopenia</sub_title>
                <counts group_id="E1" subjects_affected="50" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="167" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="178" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Metabolic/laboratory - Other:</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="37" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="38" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Neutrophil count</sub_title>
                <counts group_id="E1" subjects_affected="18" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="88" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="106" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Platelet count decreased</sub_title>
                <counts group_id="E1" subjects_affected="54" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="159" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="162" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Prothrombin time prolonged</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Troponin I increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Weight decreased</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="51" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="72" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Weight increased</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="18" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="15" subjects_at_risk="420"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Alkalosis NOS</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Anorexia</sub_title>
                <counts group_id="E1" subjects_affected="49" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="112" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="139" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Blood bicarbonate decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="16" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="13" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Glucose tolerance impaired</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Hypercalcaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="10" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Hyperglycaemia NOS</sub_title>
                <counts group_id="E1" subjects_affected="51" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="116" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="129" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Hyperkalaemia</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="16" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="15" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Hypermagnesaemia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Hypernatremia</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="21" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="20" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Hypertriglyceridaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Hyperuricemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Hypoalbuminemia</sub_title>
                <counts group_id="E1" subjects_affected="20" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="45" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="56" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Hypocalcemia</sub_title>
                <counts group_id="E1" subjects_affected="20" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="38" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="44" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Hypoglycemia NOS</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="21" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="21" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Hypokalemia</sub_title>
                <counts group_id="E1" subjects_affected="18" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="46" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="50" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Hypomagnesemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Hyponatremia</sub_title>
                <counts group_id="E1" subjects_affected="23" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="47" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="60" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Hypophosphataemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="420"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="26" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="31" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Arthritis NOS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="21" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="23" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Bone pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Buttock pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Chest wall pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Extremity-upper (function):</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Joint disorder NOS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Muscle weakness NOS</sub_title>
                <counts group_id="E1" subjects_affected="18" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="39" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="45" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Muscle weakness, generalized or specific area (not due to neuropathy): Extremity-lower</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="31" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="26" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Muscle weakness, generalized or specific area (not due to neuropathy): Extremity-upper</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="17" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="10" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Muscle weakness, generalized or specific area (not due to neuropathy): Left-sided</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="21" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="15" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Muscle weakness, generalized or specific area (not due to neuropathy): Right-sided</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Muscle weakness, generalized or specific area (not due to neuropathy): Trunk</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Musculoskeletal/soft tissue - Other:</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="13" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="14" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Myalgia</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="13" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="22" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Neck pain</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Osteoporosis NOS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Pain in extremity</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="21" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="29" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Soft tissue necrosis: Head</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Trismus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Secondary Malignancy - possibly related to cancer treatment</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Accessory nerve disorder NOS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Arachnoiditis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Ataxia</sub_title>
                <counts group_id="E1" subjects_affected="20" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="52" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="53" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>CNS necrosis/cystic progression:</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Cerebral ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Cerebrospinal fluid leak</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Cognitive disorder</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="30" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="35" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Convulsions NOS</sub_title>
                <counts group_id="E1" subjects_affected="33" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="76" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="84" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Depressed level of consciousness</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="15" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="23" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" subjects_affected="25" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="87" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="73" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Dysgeusia</sub_title>
                <counts group_id="E1" subjects_affected="19" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="41" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="63" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Extrapyramidal disorder</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Facial nerve disorder NOS</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="14" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="12" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Glossopharyngeal nerve disorder NOS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" subjects_affected="69" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="186" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="196" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Hemorrhagic stroke</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Hydrocephalus acquired</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Hyperreflexia</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="24" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="23" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Laryngeal nerve dysfunction:</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Memory impairment</sub_title>
                <counts group_id="E1" subjects_affected="27" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="77" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="79" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Mental status changes</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Muscle weakness, generalized or specific area (not due to neuropathy): Facial</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Neuralgia NOS</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Neurology - Other:</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="30" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="32" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Neuropathy: cranial: CN VIII Hearing and balance</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Nystagmus NOS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Oculomotor nerve operation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Olfactory nerve disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Peripheral motor neuropathy</sub_title>
                <counts group_id="E1" subjects_affected="34" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="52" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="60" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Peripheral sensory neuropathy</sub_title>
                <counts group_id="E1" subjects_affected="21" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="55" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="61" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Radiculitis brachial</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Sinus pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Speech disorder</sub_title>
                <counts group_id="E1" subjects_affected="33" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="59" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="59" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Syncope vasovagal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Tremor</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="50" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="42" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Trigeminal nerve disorder NOS</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>VIth nerve disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Agitation</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="26" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="15" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Anxiety</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="48" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="41" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Confusional state</sub_title>
                <counts group_id="E1" subjects_affected="31" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="56" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="56" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" subjects_affected="19" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="51" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="61" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Euphoric mood</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Insomnia</sub_title>
                <counts group_id="E1" subjects_affected="39" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="83" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="76" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Libido decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Personality change</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="15" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="13" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Psychosis aggravated</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="420"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Bladder pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Bladder spasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Chromaturia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Cystitis NOS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Glomerular filtration rate</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Hemoglobinuria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Perforation, GU: Spermatic cord</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Pollakiuria</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="20" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="20" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Proteinuria</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Renal failure NOS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Renal/genitourinary - Other:</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Ureteric obstruction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Urethral obstruction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Urinary bladder hemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Urinary incontinence</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="14" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="21" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Urinary retention</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Urogenital hemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Breast function/lactation:</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Erectile dysfunction NOS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Gynaecomastia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Menstruation irregular</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Muscle weakness, generalized or specific area (not due to neuropathy): Pelvic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Sexual/reproductive function - Other:</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Testicular pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Vaginal discharge</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Vaginal hemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Acute respiratory distress syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Apnoea</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Aspiration</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Atelectasis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Bronchospasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" subjects_affected="14" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="49" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="53" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="34" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="37" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Epistaxis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Hiccups</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Hypoxia</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Laryngeal discomfort</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Laryngitis NOS</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Mucositis/stomatitis (clinical exam): Pharynx</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Mucositis/stomatitis (functional/symptomatic): Pharynx</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Nasal cavity/paranasal sinus reactions:</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Obstruction/stenosis of airway: Pharynx</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Pharyngolaryngeal pain</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="10" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Pleural effusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Pleural hemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Pleuritic pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Pneumonitis NOS</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Prolonged chest tube drainage or air leak after pulmonary resection:</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Pulmonary/upper respiratory - Other:</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="15" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Rhinitis allergic NOS</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="13" subjects_at_risk="420"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Acne NOS</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Alopecia</sub_title>
                <counts group_id="E1" subjects_affected="87" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="172" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="190" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Decubitus ulcer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Dermatitis exfoliative NOS</sub_title>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="62" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="76" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Dermatology/skin - Other:</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="15" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="18" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Dry skin</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="19" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="17" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Erythema multiforme</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Fat atrophy NOS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Localised exfoliation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Nail disorder NOS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Pain of skin</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Pain: Scalp</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Petechiae</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Photosensitivity reaction NOS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Pruritus</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="43" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="53" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Skin atrophy</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Skin hyperpigmentation</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="10" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Skin hypopigmentation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Sweating increased</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Ulceration:</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Urticaria NOS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="420"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Flushing</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Hematoma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Hemorrhage/bleeding - Other:</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Hot flushes NOS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Hypertension NOS</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Hypotension NOS</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="14" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Lymphoedema NOS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Phlebitis superficial</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="17" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="16" subjects_at_risk="420"/>
              </event>
              <event>
                <sub_title>Vascular - Other:</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="285"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="409"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>This was a two-stage study in which participants were registered, received concomitant RT and TMZ, and then were randomized to standard or dose-dense adjuvant TMZ. Some patients were not randomized, resulting in the third arm (No adjuvant TMZ).</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Wendy Seiferheld</name_or_title>
      <organization>Radiation Therapy Oncology Group (RTOG)</organization>
      <email>wseiferheld@acr.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

